DSGN
Price
$5.53
Change
-$0.11 (-1.95%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
314.92M
68 days until earnings call
JSPR
Price
$2.80
Change
-$0.04 (-1.41%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
45.51M
Interact to see
Advertisement

DSGN vs JSPR

Header iconDSGN vs JSPR Comparison
Open Charts DSGN vs JSPRBanner chart's image
Design Therapeutics
Price$5.53
Change-$0.11 (-1.95%)
Volume$12.58K
Capitalization314.92M
Jasper Therapeutics
Price$2.80
Change-$0.04 (-1.41%)
Volume$1.31K
Capitalization45.51M
DSGN vs JSPR Comparison Chart in %
Loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSGN vs. JSPR commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and JSPR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (DSGN: $5.64 vs. JSPR: $2.84)
Brand notoriety: DSGN and JSPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 190% vs. JSPR: 13%
Market capitalization -- DSGN: $314.92M vs. JSPR: $45.51M
DSGN [@Biotechnology] is valued at $314.92M. JSPR’s [@Biotechnology] market capitalization is $45.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileJSPR’s FA Score has 1 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • JSPR’s FA Score: 1 green, 4 red.
According to our system of comparison, both DSGN and JSPR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 5 TA indicator(s) are bullish while JSPR’s TA Score has 5 bullish TA indicator(s).

  • DSGN’s TA Score: 5 bullish, 4 bearish.
  • JSPR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, JSPR is a better buy in the short-term than DSGN.

Price Growth

DSGN (@Biotechnology) experienced а +9.51% price change this week, while JSPR (@Biotechnology) price change was -3.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

Reported Earning Dates

DSGN is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSGN($315M) has a higher market cap than JSPR($45.5M). DSGN YTD gains are higher at: -8.590 vs. JSPR (-86.717). DSGN has higher annual earnings (EBITDA): -74.31M vs. JSPR (-92.73M). DSGN has more cash in the bank: 216M vs. JSPR (39.5M). DSGN has less debt than JSPR: DSGN (1.95M) vs JSPR (2.16M). DSGN (0) and JSPR (0) have equivalent revenues.
DSGNJSPRDSGN / JSPR
Capitalization315M45.5M692%
EBITDA-74.31M-92.73M80%
Gain YTD-8.590-86.71710%
P/E RatioN/AN/A-
Revenue00-
Total Cash216M39.5M547%
Total Debt1.95M2.16M90%
TECHNICAL ANALYSIS
Technical Analysis
DSGNJSPR
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 8 days ago
88%
Bullish Trend 15 days ago
74%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFLT20.051.20
+6.37%
Confluent
PLTR158.121.40
+0.89%
Palantir Technologies
SCPH5.51-0.01
-0.18%
scPharmaceuticals
PLAB23.58-0.39
-1.63%
Photronics
IPSC0.50-0.01
-2.91%
Century Therapeutics

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with VRDN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
+6.62%
VRDN - DSGN
50%
Loosely correlated
-0.65%
IDYA - DSGN
49%
Loosely correlated
-0.28%
AURA - DSGN
48%
Loosely correlated
-0.16%
TRDA - DSGN
47%
Loosely correlated
-0.53%
CRNX - DSGN
45%
Loosely correlated
+0.82%
More

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
-2.07%
AUPH - JSPR
44%
Loosely correlated
-0.25%
ETHZ - JSPR
38%
Loosely correlated
-3.69%
AVXL - JSPR
38%
Loosely correlated
-2.43%
DSGN - JSPR
37%
Loosely correlated
+6.62%
APGE - JSPR
36%
Loosely correlated
-3.10%
More